Weekly Funding Opportunities

[Med Research]

Note Regarding NSF Biosketch Requirements:
Effective October 5, 2020, the National Science Foundation (NSF) will begin enforcing the Proposal & Award Policies & Procedures Guide (PAPPG) (NSF 20-1) requirement to use NSF-approved formats for the preparation of the Biographical Sketch and Current and Pending Support proposal documents. The NSF-approved formats are SciENcv: Science Experts Network Curriculum Vitae and an NSF fillable PDF.

The NSF Biographical Sketch<https://urldefense.com/v3/__https://www.nsf.gov/bfa/dias/policy/biosketch.jsp__;!!PhOWcWs!i8mDggbY6jt9Zd5B2FpJwehguLXpj23-h-LSkEAcXxp-lbtjwLGafyvNm1LB3k64ut9rBbacHso2a4a7fRQ$ > and Current and Pending Support<https://urldefense.com/v3/__https://www.nsf.gov/bfa/dias/policy/cps.jsp__;!!PhOWcWs!i8mDggbY6jt9Zd5B2FpJwehguLXpj23-h-LSkEAcXxp-lbtjwLGafyvNm1LB3k64ut9rBbacHso2XNgrXZ8$ > websites include links to the NSF-fillable PDF formats, updated FAQs, and instructions.

NIAID Research Education Program (R25 Clinical Trial Not Allowed)<https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/pa-files/PAR-20-289.html__;!!PhOWcWs!i8mDggbY6jt9Zd5B2FpJwehguLXpj23-h-LSkEAcXxp-lbtjwLGafyvNm1LB3k64ut9rBbacHso2p2c5_iU$ >
The overarching goal of this NIAID R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs of NIAID mission<https://urldefense.com/v3/__https://www.niaid.nih.gov/about/help-our-mission__;!!PhOWcWs!i8mDggbY6jt9Zd5B2FpJwehguLXpj23-h-LSkEAcXxp-lbtjwLGafyvNm1LB3k64ut9rBbacHso2lMabLJs$ > areas.

  *   Courses for Skills Development: It is expected that the course(s) for skills development provide innovative, state-of-the-art, evidence-based education that relates to the mission of NIAID, and is derived from biomedical, behavioral or clinical research findings. For example, advanced courses in a specific discipline or research area, clinical procedures for research, specialized research techniques, or research methodology. The courses may include elements that promote research skills and career skills of the participants. The format of the courses may involve a traditional in-person approach, online activities, a hybrid of both approaches, or other methods.
  *   Research Experiences: It is expected that the research experiences supported by this FOA are relevant to the trainees area of science, yet sufficiently different such that it expands or extends their skills. The expanded experience has to meet the needs and career level of participants. Research experiences must also be designed to address some area of NIAID extramurally supported research. For example, for graduate and health professional students: to provide research experiences and related training not available through formal NIH training mechanisms; to provide hands-on authentic research experiences that reflect ownership of a project and provide opportunity for meaningful contribution to the research in question, and stimulate their interest to consider further education and training for future research related to the NIAID mission; for postdoctorates and junior faculty: to extend their skills, experiences, and knowledge base and prepare them for a NIAID-related career research.
  *   Mentoring Activities: Within the context of a mentoring network activities may include, but are not limited to, dedicated efforts at providing technical expertise, advice, insight, and professional career skills that advance the broad career goals of graduate students, postdoctorates and/or early-career faculty; facilitating scholarly writing and grantsmanship; promoting successful transitions from one career stage to another; providing leadership development; helping to identify potential collaborators; helping to establish interdisciplinary or translational collaborations in order to foster a career trajectory towards independent NIAID-related research.
Due December 7, 2020; December 7, 2021; and December 7, 2022. Med-RA deadline to receive draft documents for December 2020 due date: November 23.

NSF’s Collaborative Research in Computational Neuroscience (CRNS): Innovative Approaches to Science and Engineering Research on Brain Function<https://urldefense.com/v3/__https://www.nsf.gov/pubs/2020/nsf20609/nsf20609.htm__;!!PhOWcWs!i8mDggbY6jt9Zd5B2FpJwehguLXpj23-h-LSkEAcXxp-lbtjwLGafyvNm1LB3k64ut9rBbacHso2RlyJNkA$ >
Computational neuroscience provides a theoretical foundation and a rich set of technical approaches for understanding complex neurobiological systems, building on the theory, methods, and findings of computer science, neuroscience, and numerous other disciplines. Through the CRCNS program, the U.S. National Science Foundation (NSF), National Institutes of Health (NIH), and Department of Energy (DOE); the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF); the French National Research Agency (Agence Nationale de la Recherche, ANR); the United States-Israel Binational Science Foundation (BSF); Japan’s National Institute of Information and Communications Technology (NICT); and Spain’s State Research Agency (Agencia Estatal de Investigación, AEI) and National Institute of Health Carlos III (Instituto de Salud Carlos III, ISCIII) support collaborative activities that will advance the understanding of nervous system structure and function, mechanisms underlying nervous system disorders, and computational strategies used by the nervous system. Two classes of proposals will be considered in response to this solicitation:
Research Proposals describing collaborative research projects.
Data Sharing Proposals to enable sharing of data and other resources.
Due December 10, 2020; November 23, 2021; November 22, 2022. Med-RA deadline to receive draft documents for December 2020 due date: November 30.

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 / R01 Clinical Trial Optional)
R21<https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/pa-files/PAR-20-299.html__;!!PhOWcWs!i8mDggbY6jt9Zd5B2FpJwehguLXpj23-h-LSkEAcXxp-lbtjwLGafyvNm1LB3k64ut9rBbacHso2z49cW3U$ >
R01<https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/pa-files/PAR-20-300.html__;!!PhOWcWs!i8mDggbY6jt9Zd5B2FpJwehguLXpj23-h-LSkEAcXxp-lbtjwLGafyvNm1LB3k64ut9rBbacHso2PNw0Thg$ >
The purpose of these funding opportunity announcements is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric precision therapeutics.
Due December 10, 2020; April 9, 2021; August 10, 2021; December 10, 2021; April 11, 2022; August 10, 2022; and December 9, 2022. Med-RA deadline to receive draft documents for December 2020 due date: November 30.

BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed)<https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-556.html__;!!PhOWcWs!i8mDggbY6jt9Zd5B2FpJwehguLXpj23-h-LSkEAcXxp-lbtjwLGafyvNm1LB3k64ut9rBbacHso2GeB2T_8$ >
This Funding Opportunity Announcement (FOA) from the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is intended to support the development of technologies, production efforts, and dissemination resources for a cell type-specific armamentarium to study brain function across species. The goal is to promote evaluation of molecular or genetic technologies and creation of pilot production and distribution resources for cell type-specific access and manipulation reagents for several vertebrate species, including in human ex vivo tissues or cells. Demonstration projects are sought that would develop reagents that: (1) enable access to molecularly defined neural cell types in a complex brain region or significant brain network of a vertebrate; (2) are easily produced, disseminated, utilized, and stored; and (3) are catalogued for users in a brain atlas. In addition to the above required features, reagents are also sought that exhibit the following qualities: (4) are applicable to both genetically tractable and less tractable vertebrate organisms; (5) exhibit high specificity and efficiency of targeting; (6) show low toxic or perturbative effects; (7) provide flexibility to deliver various reporter, sensor, and effector payloads and are compatible with other methods of access to brain cell types; and (8) are potentially usable in human ex vivo brain tissue or cells. The pilot projects should be scalable in the future. The long-term goal of a potentially scaled-up effort is to achieve near comprehensive, molecular access for monitoring and manipulation reagents in each defined cell type of vertebrate brains relevant to neuroscience research.
Due February 11, 2021 and October 19, 2021. Med-RA deadline to receive draft documents for February 2021 due date: February 1.

Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)<https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-051.html__;!!PhOWcWs!i8mDggbY6jt9Zd5B2FpJwehguLXpj23-h-LSkEAcXxp-lbtjwLGafyvNm1LB3k64ut9rBbacHso2-NuL42Q$ >
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to develop, adapt, and test individual-, community- or multilevel interventions to address modifiable risk factors for cancer in rural populations. Applications should focus on primary prevention and assess and address one or more of the social and behavioral risk factors that contribute to cancer disparities in rural populations: tobacco use; diet, physical activity and weight; alcohol use; UV exposure; and HPV vaccination. Applications should also assess and address myriad social determinants of health, cultural factors, and health care and technology access barriers that may contribute to rural cancer disparities. This FOA also encourages implementation science research, to incorporate efficacious cancer control interventions in a coordinated way, into broader, sustainable health programs that are designed to reach rural populations and allow local customization and adaptation.
Due March 15, 2021 and January 18, 2022. Med-RA deadline to receive draft documents for March 2021 due date: March 2.

Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)<https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/pa-files/PAR-20-298.html__;!!PhOWcWs!i8mDggbY6jt9Zd5B2FpJwehguLXpj23-h-LSkEAcXxp-lbtjwLGafyvNm1LB3k64ut9rBbacHso2FA5u5rc$ >
The purpose of this Funding Opportunity Announcement is to understand the contribution of specific elements of maternal molecular and cellular factors that can control and effect the development of the fetal immune system.
Due April 7, 2021; December 7, 2021; April 7, 2022; December 7, 2022; April 7, 2023; and December 7, 2023. Med-RA deadline to receive draft documents for April 2021 due date: March 25.

Modules for Enhancing Biomedical Research Workforce Training (R25 Clinical Trial Not Allowed)<https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/pa-files/PAR-20-296.html__;!!PhOWcWs!i8mDggbY6jt9Zd5B2FpJwehguLXpj23-h-LSkEAcXxp-lbtjwLGafyvNm1LB3k64ut9rBbacHso28AM9oP0$ >
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:

  *   Curriculum or Methods Development
Specifically, this FOA will support the development of training modules designed to be freely available, at no cost to the broader community to enhance training of the biomedical research workforce. Responsive topics will be indicated through Notices of Special Interest (NOSIs) released annually by NIGMS.
Due June 18, 2021; June 20, 2022; and June 19, 2023. Med-RA deadline to receive draft documents for June 2021 due date: June 7.

To search for additional funding opportunities, please visit CoM’s unofficial funding opportunities blog<https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV6980C-DCl-AxzFLHMVYQ&e=>.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.fsu.edu/pipermail/com_funding_opportunities/attachments/20200921/9257a383/attachment.html>